Venous tromboembolism treatment: budget impact analysis of rivaroxaban in Italy
نویسندگان
چکیده
منابع مشابه
Rituximab in the treatment of rheumatoid arthritis patients in Italy: a budget impact analysis.
OBJECTIVES The objective of this Budget Impact Analysis is to evaluate the financial implications of a rituximab-based sequencing strategy in the treatment of rheumatoid arthritis in the perspective of the Italian National Health Service. METHODS Yearly patients who were eligible for a second-line biological DMARD in Italy were entered into a 5-year model. A Markov chain reproduced the course...
متن کاملTreatment of Cerebral Venous Thrombosis with Rivaroxaban
Stroke Unit, Emergency Department, San Camillo Hospital, Rome, Italy *Corresponding author: Anticoli S, MD, Stroke Unit, Emergency Department, San Camillo Hospital, Rome, Italy, E-mail: [email protected] Rec Date: Mar 07, 2016; Acc Date: Apr 27, 2016; Pub Date: May 05, 2016 Copyright: © 2016 Anticoli S, et al. This is an open-access article distributed under the terms of the Cr...
متن کاملAcamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy
OBJECTIVE Alcohol dependence is a common condition associated with high direct and indirect health care costs. The purpose of this analysis was to estimate the economic consequences of acamprosate used as adjuvant therapy in the treatment of alcoholism, defining a budget impact analysis (BIA) from the point of view of the Italian National Health Service (NHS). METHODS We developed a model of ...
متن کاملRivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
BACKGROUND Although many patients with venous thromboembolism require extended treatment, it is uncertain whether it is better to use full- or lower-intensity anticoagulation therapy or aspirin. METHODS In this randomized, double-blind, phase 3 study, we assigned 3396 patients with venous thromboembolism to receive either once-daily rivaroxaban (at doses of 20 mg or 10 mg) or 100 mg of aspiri...
متن کاملIntroduction of a quadrivalent influenza vaccine in Italy: a budget impact analysis
Every year in Italy, the Ministry of Health (MoH) offers influenza vaccination free of charge to all subjects at risk and to all subjects aged ≥ 65 year old. Until 2014-2015 immunization campaign against Trivalent Influenza Vaccine (TIVs) were the only vaccines used in Italy. Traditional TIVs contain antigens from three viral strains: A(H1N1), A(H3N2), and one of the two B lineages: B(Victoria)...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Farmeconomia. Health economics and therapeutic pathways
سال: 2014
ISSN: 2240-256X
DOI: 10.7175/fe.v15i4.968